Craft

RTI Surgical

Stock Price

$1.7

2021-01-28

Market Capitalization

$234.2 M

2021-01-28

Revenue

$280.9 M

FY, 2018

RTI Surgical Summary

Company Summary

Overview
RTI Surgical is a global surgical implant company providing surgeons with safe biologic, metal and synthetic implants. The Company's business primarily consists of six categories, such as spine, sports medicine, ortho fixation, bone graft substitutes and general orthopedic (BGS and general orthopedic), dental and surgical specialties. RTI Surgical processes donated human musculoskeletal and other tissue, including bone, cartilage, tendon, ligament, fascia lata, pericardium, sclera and dermal tissue, and bovine and porcine animal tissue in producing allograft and xenograft implants.
Type
Public
Status
Active
Founded
1998
HQ
Alachua, FL, US | view all locations
Website
http://www.rtix.com
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • Camille I. Farhat

    Camille I. Farhat, President and Chief Executive Officer

    • Jonathon M. Singer

      Jonathon M. Singer, Chief Financial and Administrative Officer, Corporate Secretary

      • Lennox K. Archibald

        Lennox K. Archibald, Medical Director

        • Julius Aviza

          Julius Aviza, Vice President, Global Quality Assurance

          Operating MetricsView all

          Facilities

          5

          FY, 2016

          Countries

          45

          FY, 2016

          LocationsView all

          8 locations detected

          • Alachua, FL HQ

            United States

            11621 Research Cir

          • Greenville, NC

            United States

            1800 N Greene St

          • Marquette, MI

            United States

            375 River Park Cir

          • Raleigh, NC

            United States

            11550 Common Oaks Dr #201

          • Metz, Alsace-Champagne-Ardenne-Lorraine

            France

          • Neunkirchen am Brand, Bayern

            Germany

            6 Industriestraße

          and 2 others

          RTI Surgical Financials

          Summary Financials

          Revenue (FY, 2018)
          $280.9M
          Gross profit (FY, 2018)
          $140.1M
          Net income (FY, 2018)
          ($1.3M)
          Cash (FY, 2018)
          $10.9M
          EBIT (FY, 2018)
          ($2.5M)
          Enterprise value
          $322.4M

          Footer menu